Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National Medical Products Administration (NMPA), which announced its approval the same day.

Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...

Global pharmaceutical company Sanofi is partnering with Healx, a U.K.-based clinical-stage biotech specializing in rare diseases, to use its artificial intelligence to identify novel rare disease ...

For its “Allegra Airways” campaign, the allergy medication brand used real-time pollen and air pollution data to find pockets ...

To combat this, allergy medication Allegra created Allegra Airways, a website designed to help find and map real-time routes ...

which align with our commitment to advancing transformative therapies for unmet medical needs.” Julien Dodet President of the Governing Board, Orano Med “Sanofi’s partnership with Orano Med ...

But Sanofi said efforts will focus on difficult-to-treat cancers, both hematological malignancies and solid tumors that have critical unmet medical need, including rare cancers such as multiple ...

Approximately $30 million of this current quarter amount is related to commercial and medical affairs related ... economics ...

As usual, you can find the slides on sanofi.com. Please turn to slide number ... where COPD is a huge unmet medical need due to widespread [indiscernible] in the local population.

Global medical companies are launching hundreds of state-of-the-art technologies in the medical product pavilion of the ...

Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...